People's vaccine? Will the wealthiest countries control coronavirus drugs?

People’s vaccine? Will the wealthiest countries control coronavirus drugs?

Prime Minister Boris Johnson characterized Britain’s exit from the European Union as “recaptured sovereignty.” These invocations of sovereign power reflect ...
picture

Anti-GMO movement merging with anti-vaccine groups, escalating threat to global coronavirus response

As scientists around the world work at an unprecedented pace to develop a vaccine for COVID-19, anti-vaccine proponents are planting ...
im

Wanted: Volunteers willing to risk getting sick from the coronavirus for the greater good

The Covid-19 Prevention Network, which knits together the existing federal clinical trial infrastructure developed largely to test HIV vaccines and ...
vaccine

‘It’s not premature to plan’: Deciding who gets the coronavirus vaccine first

The new coronavirus’ disproportionate toll on the elderly could put them at the front of the line [for a vaccine] ...
unnamed file

Viewpoint: Telescoping coronavirus vaccine testing and approval timelines exposes all of us to unnecessary dangers

We all hope for a rapid end to the pandemic and an effective vaccine would be a surefire solution. But ...
bxorbfaw a

Big risk, big rewards: Betting on RNA to make cheaper, faster coronavirus vaccines

[A] promising — but unproven — new generation of vaccine technologies is based on deploying a tiny snip of genetic ...
vaccine prices

Crisis on the horizon? Nothing limits virus vaccine makers from charging exorbitant fees

[A] Covid-19 vaccine will have an actual price tag. And given the prevailing business-centric model of American drug pricing, it ...
dd db a fae a c

The rich get safer? Developing countries likely last in line to get virus vaccine

Worldwide, about a dozen potential COVID-19 vaccines are in early stages of testing. While some could move into late-stage testing ...
oemlubzrpehor zsnv h qwslxmwgnmhkvj h l

First COVID-19 vaccines on track to arrive late 2020, faster than thought possible

Three companies with funding from the US government—AstraZeneca, Johnson & Johnson, and Moderna—are on track to distribute the first commercial ...
grocery web apr ap x

Even with a vaccine, COVID-19 might be here to stay. Here’s what that means for society

It is a daunting proposition — a coronavirus-tinged world without a foreseeable end. But experts in epidemiology, disaster planning and ...
coronavirus therapy research

FDA won’t approve a coronavirus vaccine unless there is ‘clearly demonstrated proof’ it’s effective

[A coronavirus vaccine must] be at least 50% more effective than a placebo in preventing the disease [to be FDA ...
thumbs b c e a e ca b ed bb ea bfb

Quest for a coronavirus vaccine ‘reinvigorating’ anti-vax conspiracy theories

There is no COVID-19 vaccine, but there are already COVID-19 vaccine conspiracies. Even as vaccines for the disease caused by ...
unnamed

Will herd immunity curb COVID-19? Not with rampant spread of ‘anti-science, anti-authority, anti-vaccine’ views

With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months ...
vaccine

Viewpoint: Human challenge trials – volunteers intentionally infected with COVID-19 – are ‘uninformative, unnecessary and unethical’

Deliberately infecting volunteers with SARS-CoV-2 to test the efficacy of vaccine candidates is unnecessary, uninformative, and unethical. … [O]ne prominent ...
tailandia entra en la carrera por vacunas contra el coronavirus scaled

Viewpoint: Just one COVID-19 vaccine is not enough to win the war. We need an army

Scientists have created more than 70 vaccine candidates so far. “If we end up with two, three, or four vaccines, ...
edea f a

Is speed more important than safety? Operation Warp Speed triggers public fears regulators are cutting coronavirus vaccine corners

"I'm a bit concerned to see there's a fair amount of skepticism in the American public about whether or not ...
antibody therapy covid x

5 percent of COVID-19 survivors have super strength ‘neutralizing antibodies’ crucial for developing a vaccine

The discovery of antibodies that block the most infectious elements of the coronavirus is helping Bay Area scientists unlock the ...
super potent covid neutralizing antibodies isolated and successfully tested in animals

COVID-19 recoverers appear to rapidly lose antibodies, leaving them vulnerable to reinfection within months

Infections caused by coronavirus cousins such as SARS and MERS result in antibodies that remain in the body for nearly ...
x

Polio vaccines are inexpensive, easily available, already approved—and they might work wonders against COVID-19

Recent reports indicate that COVID-19 may result in suppressed innate immune responses. Therefore, stimulation by live attenuated vaccines [such as ...
download

Is the FDA facing political pressure to rush through approval of untested COVID-19 vaccines to fit Trump’s political schedule?

President Donald Trump has promised that there will be a coronavirus vaccine before the year is out. But public health ...
covid immunity

Why controlling COVID-19 outbreaks could make it harder to test a vaccine

The aim is a vaccine by January, and money is no object. On May 21, the US said it would ...
download

3 experimental COVID-19 vaccines set for critical testing phase this summer

The federal government plans to fund and conduct the decisive studies of three experimental coronavirus vaccines starting this summer, according ...
health coronavirus herd hpmain x

Why a poorly designed coronavirus vaccine could actually make infections worse

Antibodies created during a first-time infection could, under very specific circumstances, end up enhancing the disease rather than protecting against ...
ec d e f eb a

COVID-19 vaccines unlikely to be ‘cure-alls’. That might not be such a bad thing

With a little luck and a lot of science, the world might in the not-too-distant future get vaccines against Covid-19 ...
virus vaccines superjumbo

Viewpoint: Believing that we’ll have a COVID-19 vaccine anytime soon is naive

The odds that we will have a safe, effective vaccine by January are vanishingly small ...
people on park bench imgcache rev ec f ed d bea cce e b

‘That’s not easy’: Figuring out who gets first shot at a coronavirus vaccine

Even if scientists do develop a safe, broadly effective vaccine, nobody knows how to give it to billions of people ...
thumbs b c d f e e e e c fe

Infographic: 8 ways we can defeat the coronavirus

More than 90 vaccines are being developed against SARS-CoV-2 by research teams in companies and universities across the world. Researchers ...
ap sq b de b ffc b dd e b f b s c

First, we need a coronavirus vaccine. Then we need to figure out who gets it first

Several drugmakers that have been building up their capabilities to make coronavirus vaccines, have pledged to deliver millions of doses ...